Although higher antibody concentrations to PT have been shown to correlate in general with better clinical protection [8–11], some individuals with high antibody concentrations after Tdap vaccination still contract typical pertussis disease [9], which emphasizes the importance of determining the functional characteristics of antibodies for establishing correlates for protection [12]. Here, F2 is linked to pertussis.